Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer

NCT04108481 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped DSMC-directed closure

Conditions

Colorectal Cancer Metastatic
Colon Cancer
Metastatic Colorectal Cancer
Rectal Cancer
Liver Metastasis Colon Cancer
Colo-rectal Cancer
Colorectal Adenocarcinoma
Colorectal Neoplasms
Liver Metastases
Colorectal Carcinoma

Interventions

DRUG: Durvalumab
RADIATION: Yttrium-90 RadioEmbolization

Sponsor

University of Iowa

Collaborators

[object Object]
[object Object]